BRIEF-Intrexon to Develop Disease-Modifying Therapies in New Collaborations with Harvest Intrexon Enterprise Fund

* Entered into exclusive channel collaborations with Genten Therapeutics, CRS Bio, cos backed by Harvest Intrexon Enterprise Fund
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.